The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 30, 2023
Filed:
Jun. 20, 2019
Applicant:
Taiwanj Pharmaceuticals Co., Ltd., Zhubei, TW;
Inventors:
Syaulan S. Yang, Zhubei, TW;
Kuang Yuan Lee, Hsinchu, TW;
Meng Hsien Liu, Toufen, TW;
Yan-Feng Jiang, Kaohsiung, TW;
Yu-Shiou Fan, Taipei, TW;
Chiung Wen Wang, Zhubei, TW;
Mei-Chi Hsu, Tainan, TW;
Assignee:
TAIWANJ PHARMACEUTICALS CO., LTD., Zhubei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/26 (2006.01); C07D 223/16 (2006.01); C07D 401/10 (2006.01); C07D 409/04 (2006.01); C07D 491/056 (2006.01); C07D 495/04 (2006.01);
U.S. Cl.
CPC ...
C07D 223/16 (2013.01); C07D 215/26 (2013.01); C07D 401/10 (2013.01); C07D 409/04 (2013.01); C07D 491/056 (2013.01); C07D 495/04 (2013.01);
Abstract
The present disclosure relates to a compound of Formula I, or a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug or solvate thereof. The present disclosure further relates to a composition comprising the compound of Formula (I). The compound and the composition described herein can be used to inhibit NADPH oxidase activity.